Repurposing FDA-approved drugs to treat chemical weapon toxicities: Interactive case studies for trainees.

ABSTRACT: The risk of a terrorist attack in the United States has created challenges on how to effectively treat toxicities that result from exposure to chemical weapons. To address this concern, the United States has organized a trans-agency initiative across academia, government, and industry to identify drugs to treat tissue injury resulting from exposure to chemical threat agents. We sought to develop and evaluate an interactive educational session that provides hands-on instruction on how to repurpose FDA-approved drugs as therapeutics to treat toxicity from exposure to chemical weapons. As part of the Rutgers Summer Undergraduate Research Fellowship program, 23 undergraduate students participated in a 2-h session that included: (1) an overview of chemical weapon toxicities, (2) a primer on pha

SUBMITTER: Aleksunes LM 

PROVIDER: S-EPMC11223991 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature